TALPHERA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.02 USD | -2.86% |
|
-16.05% | +38.78% |
| 05-14 | Transcript : Talphera, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 05-14 | Talphera, Inc. Appoints Dr. Shakil Aslam as Chief Development Officer, Effective May 20, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 17.33M | - | - | - | - | - | |
| 79.38B | - | - | ||||
| 8.74B | ||||||
| 4.94B | ||||||
| 4.7B | - | - | ||||
| 3.98B |
- Stock Market
- Equities
- TLPH Stock
- Charts Talphera, Inc.
- Sector Chart
